Monday morning was a dull one at Wave Life Sciences (NASDAQ:WVE). This was because the company’s shares declined by 50%. About the flop Analysts attribute this major drop to the recent discontinuation of the company’s suvodirsen. It was a product under development to help patients struggling with a condition known as Duchenne muscular dystrophy. DMD […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 43 views
- China Unveils Maglev Train With a Top Speed of 600 kph 40 views
- Expect a Fierce Race Between VW and Tesla Says VW CEO 37 views
- Apple to Provide Other Payment Methods in Dating Apps Says Dutch Watchdog 32 views
- Tata Motors Eyeing to Acquire Ford’s Factory in India 30 views